Keynote by Dr. Rea Lehner on Enhancing Drug Development: The Role of Digital Health Technologies in Clinical Trials, 6 May 2025
Tuesday, 6 May 2025, 4.15 pm CET, Hybrid ITEM A24-0-216 or ZOOM
About Rea Lehner
Dr. Rea Lehner is a passionate professional dedicated to transforming healthcare through technology and data. With extensive experience in leading digital health projects from proof-of-concept to large-scale implementation in academic and pharmaceutical settings, she has contributed to clinical trials in neurological, neurodevelopmental, and autoimmune diseases. She previously co-led a research program at the Singapore-ETH Centre focused on developing digital health technologies and innovative concepts in close collaboration with local clinical partners and governmental agencies to meet future healthcare needs. Dr. Rea Lehner currently serves as the Digital Biomarker Science and Technology Lead at Roche, where she leads cross-functional teams to develop and implement remote patient monitoring solutions in drug development.
About the Lecture
The keynote on Digital Health Technologies (DHTs) in drug development will explore how digital endpoints transform the pharmaceutical landscape. By enhancing the precision of data collection, improving decision-making in clinical trials, and boosting patient recruitment and retention, these technologies may provide more objective measures than traditional methods. They enable continuous data collection that reflects real-world conditions. Additionally, the value drivers of digital endpoints will be discussed, including their role in better monitoring patient safety, offering earlier insights into treatment efficacy, achieving cost savings by reducing sample sizes and trial durations, and facilitating product differentiation, which influences label claims and post-marketing strategies.
We are pleased to invite you to join this guest lecture, which is part of our CDHI Lecture Series Digital Health Forum. Registration is not required. Please be aware that we will be recording this guest lecture and will be making it available in our teaching library. If you have any questions, please contact Victoria Brügger (victoria.bruegger@unisg.ch) prior to the start of the guest lecture.
Prof. Dr. Tobias Kowatsch, Associate Professor for Digital Health Interventions, Institute for Implementation Science in Health Care, University of Zurich; Director, School of Medicine, University of St.Gallen (HSG); Scientific Director, Centre for Digital Health Interventions (CDHI), ETH Zurich & HSG; Principal Investigator, Future Health Technologies programme, Campus for Research Excellence and Technological Enterprise (CREATE), Singapore-ETH Centre, Singapore
Prof. Dr. Elgar Fleisch, Professor of Information Management, ETH Zürich; Professor of Technology Management, University of St.Gallen; Advisory Board Member, CDHI, ETH Zürich & University of St.Gallen; Principal Investigator, Future Health Technologies programme, Campus for Research Excellence and Technological Enterprise (CREATE), Singapore-ETH Centre, Singapore
Prof. Dr. Florian von Wangenheim, Professor of Technology Marketing, ETH Zurich & Advisory Board Member, CDHI; Principal Investigator, Future Health Technologies programme, Campus for Research Excellence and Technological Enterprise (CREATE), Singapore-ETH Centre, Singapore
